Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …
underscores the urgent need for enhanced insights into the molecular and cellular …
New directions in the therapy of glioblastoma
K Szklener, M Mazurek, M Wieteska, M Wacławska… - Cancers, 2022 - mdpi.com
Simple Summary Despite the continuous development of treatment technology,
glioblastoma remains a challenge for modern medicine. The standard of care remains a …
glioblastoma remains a challenge for modern medicine. The standard of care remains a …
[HTML][HTML] Ugonin P inhibits lung cancer motility by suppressing DPP-4 expression via promoting the synthesis of miR-130b-5p
Lung cancer is the leading cause of cancer-related death worldwide, and the survival rate of
metastatic lung cancer is exceedingly low. Helminthostatchys Zeylanica (H. Zeylanica) is a …
metastatic lung cancer is exceedingly low. Helminthostatchys Zeylanica (H. Zeylanica) is a …
In silico strategies for designing of peptide inhibitors of oncogenic K-ras G12V mutant: inhibiting cancer growth and proliferation
Simple Summary The most well-known oncogene and one with the highest rates of mutation
across all cancers is K-Ras, also known as the Kirsten rat sarcoma viral oncogene …
across all cancers is K-Ras, also known as the Kirsten rat sarcoma viral oncogene …
Targeting KRAS in colorectal cancer: a bench to bedside review
Colorectal cancer (CRC) is a heterogeneous disease with a myriad of alterations at the
cellular and molecular levels. Kristen rat sarcoma (KRAS) mutations occur in up to 40% of …
cellular and molecular levels. Kristen rat sarcoma (KRAS) mutations occur in up to 40% of …
Navigating the ERK1/2 MAPK cascade
A Martin-Vega, MH Cobb - Biomolecules, 2023 - mdpi.com
The RAS-ERK pathway is a fundamental signaling cascade crucial for many biological
processes including proliferation, cell cycle control, growth, and survival; common across all …
processes including proliferation, cell cycle control, growth, and survival; common across all …
The current landscape of the antimicrobial peptide melittin and its therapeutic potential
HQ Zhang, C Sun, N Xu, W Liu - Frontiers in Immunology, 2024 - frontiersin.org
Melittin, a main component of bee venom, is a cationic amphiphilic peptide with a linear α-
helix structure. It has been reported that melittin can exert pharmacological effects, such as …
helix structure. It has been reported that melittin can exert pharmacological effects, such as …
Tumor Cell Resistance to the Inhibition of BRAF and MEK1/2
W Chen, JI Park - International Journal of Molecular Sciences, 2023 - mdpi.com
BRAF is one of the most frequently mutated oncogenes, with an overall frequency of about
50%. Targeting BRAF and its effector mitogen-activated protein kinase kinase 1/2 (MEK1/2) …
50%. Targeting BRAF and its effector mitogen-activated protein kinase kinase 1/2 (MEK1/2) …
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations
Purpose: Myeloproliferative neoplasms (MPN) are characterized by the overproduction of
differentiated myeloid cells. Mutations in JAK2, CALR, and MPL are considered drivers of …
differentiated myeloid cells. Mutations in JAK2, CALR, and MPL are considered drivers of …
Development and In Vitro Evaluation of Crizotinib-Loaded Lipid–Polymer Hybrid Nanoparticles Using Box–Behnken Design in Non-small Cell Lung Cancer
P Korucu Aktas, I Baysal, S Yabanoglu-Ciftci… - AAPS PharmSciTech, 2023 - Springer
The goal of the study was to produce, optimize, characterize, and compare crizotinib-loaded
lipid-polymer hybrid nanoparticles (CL-LPHNPs), representing a novel contribution to the …
lipid-polymer hybrid nanoparticles (CL-LPHNPs), representing a novel contribution to the …